Yahoo Web Search

Search results

1. • Great Lakes Advisors LLC Has $1.11 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

     ETF DAILY NEWS· 2 days ago

     Great Lakes Advisors LLC trimmed its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 50.8% during the fourth quarter, according to its most recent 13F filing with the ...

2. • Aster Insights, ORIEN to Present Research Abstracts at the 60th ASCO Annual Meeting

     CBS 47 Fresno· 3 days ago

     Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced the company and members of the Oncology Research Information Exchange Network ...

3. • Principal Financial Group Inc. Trims Holdings in Exelixis, Inc. (NASDAQ:EXEL)

     ETF DAILY NEWS· 5 days ago

     Principal Financial Group Inc. lowered its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 2.9% during the 4th quarter, according to the company in its most recent disclosure ...

4. • Exelixis (NASDAQ:EXEL) Now Covered by Stephens

     ETF DAILY NEWS· 6 days ago

     Stephens started coverage on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report issued on Tuesday morning, MarketBeat Ratings reports. The firm issued an equal weight rating and a $23.00 ...

5. • Swiss National Bank Has $3.57 Million Stock Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

     ETF DAILY NEWS· 3 days ago

     Swiss National Bank lowered its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the ...

6. • Natixis Advisors L.P. Cuts Holdings in Exelixis, Inc. (NASDAQ:EXEL)

     ETF DAILY NEWS· 5 days ago

     Natixis Advisors L.P. lessened its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 3.1% in the fourth quarter, according to the company in its most recent Form 13F filing ...